Is Zelira Therapeutics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Zelira Therapeutics Ltd (ZLD.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Zelira Therapeutics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Zelira Therapeutics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Zelira Therapeutics Ltd?

Muslim investors may consider investing in Zelira Therapeutics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Zelira Therapeutics Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Zelira Therapeutics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Zelira Therapeutics Ltd updated?

The Shariah compliance status of Zelira Therapeutics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Zelira Therapeutics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Zelira Therapeutics Ltd?

You can check the latest Shariah compliance status of Zelira Therapeutics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

ZLD.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 31, 2025

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Zelira Therapeutics Ltd (ZLD.AX)

Based on 5 analysts giving stock ratings to Zelira Therapeutics Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Zelira Therapeutics Ltd. Stock Analysis ZLD.AX

Australia Health Care Nano Cap Report: Q2, 2025

Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. The firm is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. The company is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. The company has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The firm in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.

Key Statistics of Zelira Therapeutics Ltd (ZLD.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.49AUD0.50

Today's Open

AUD0.50

Volume

19.14K

P/E Ratio (TTM)

52 Week Range

AUD0.31AUD1.15

Market Cap

5.95M

Avg. Volume

2042.50

Dividend Yield

Financial Metrics & Statements of Zelira Therapeutics Ltd (ZLD.AX)

FAQ's for Zelira Therapeutics Ltd (ZLD.AX)

According to Musaffa’s Shariah screening methodology, Zelira Therapeutics Ltd (ZLD.AX) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.